HIV-Associated Facial Lipoatrophy
	
Dermatologic Surgery
2002 Abstract
0211-979 James
James J, Carruthers A, Carruthers J.
HIV-associated facial lipoatrophy. Dermatol Surg. 2002 Nov;28(11):979-86. PMID: 12460289
Division of Dermatology and Department of Ophthalmology, University of British Columbia, Vancouver,British Columbia, Canada.
	BACKGROUND:
	HIV-infected individuals are living long, healthy lives. They are now concerned with less life-threatening problems, especially lipodystrophy.
	OBJECTIVE: 
	To review the current state of our knowledge about lipodystrophy in HIV-infected individuals. 
	METHODS: 
	The literature was reviewed and analyzed for relevant information. In addition, our clinical experience of managing such individuals was utilized.
	RESULTS: 
	Lipodystrophy and facial lipoatrophy and their relationship to HIV-infection are discussed. Their differences are noted. The spectrum of appearance in individuals with facial lipoatrophy is described and a severity scale suggested which should be of value in assessing the results of treatment.
	CONCLUSION:
	Lipodystrophy and lipoatrophy are intimately related to infection with HIV. In consequence, facial lipoatrophy is a major stigma for HIV-infected individuals and can have dramatic effects on their self-esteem and socialization. Effective treatment is essential.
	Publication Types:
	Review
	Review, Tutorial
